Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Autonomous University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9351
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Autonomous University of Barcelona (UAB) is a public university that offers education, research and knowledge transfer services. The university provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. It offers educational programs in the areas of arts and science; humanities, social sciences and law, philosophy, economics and medicine, speech therapy, computational mathematics and data analytics, among others. The university also conducts research activities in the fields of animal and food science; medicine; pharmacology, therapeutics and toxicology; psychiatry and legal medicine, surgery, computer science, animal health and anatomy; experimental and technological sciences, social sciences, and others. UAB is headquartered in Barcelona, Spain.

Autonomous University of Barcelona – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 10
Licensing Agreements 11
Kogenix Therapeutics Enters into Licensing Agreement with University of Barcelona and Vall d’Hebron Research 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
Autonomous University of Barcelona – Key Competitors 13
Autonomous University of Barcelona – Key Employees 14
Autonomous University of Barcelona – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Feb 20, 2018: RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease 16
Product News 18
Jun 07, 2018: First photoactive drug to fight Parkinson’s disease 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Key Facts 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Deals By Therapy Area, 2012 to YTD 2018 8
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 10
Kogenix Therapeutics Enters into Licensing Agreement with University of Barcelona and Vall d'Hebron Research 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
Autonomous University of Barcelona, Key Competitors 13
Autonomous University of Barcelona, Key Employees 14
Autonomous University of Barcelona, Subsidiaries 15

List of Figures
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dangote Cement Plc:企業の戦略・SWOT・財務情報
    Dangote Cement Plc - Strategy, SWOT and Corporate Finance Report Summary Dangote Cement Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Department of Defense Education Activity:企業の戦略的SWOT分析
    Department of Defense Education Activity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Verisante Technology Inc:企業の戦略的SWOT分析
    Verisante Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Banco de Sabadell SA:企業の戦略・SWOT・財務情報
    Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report Summary Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alnylam Pharmaceuticals Inc (ALNY):医療機器:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Investec Private Bank (South Africa):企業の戦略・SWOT・財務情報
    Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ansell Limited:企業の戦略・SWOT・財務分析
    Ansell Limited - Strategy, SWOT and Corporate Finance Report Summary Ansell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務情報
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Columbus McKinnon Corp (CMCO):企業の財務・戦略的SWOT分析
    Summary Columbus McKinnon Corp (CMCO) is an industrial equipment company that offers cranes and hoists. The company designs, manufactures and markets material handling systems and services, which are used for moving, lifting, positioning and securing materials. Its products include hoists, actuators …
  • South Jersey Industries, Inc. (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Weihai Guangtai Airport Equipment Co., Ltd.:企業の戦略・SWOT・財務情報
    Weihai Guangtai Airport Equipment Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Weihai Guangtai Airport Equipment Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comp …
  • Equinor ASA.:企業の戦略・SWOT・財務分析
    Equinor ASA. - Strategy, SWOT and Corporate Finance Report Summary Equinor ASA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Sandoz International GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • Alamo Group, Inc.:戦略・SWOT・企業財務分析
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Solco Biomedical Co Ltd (043100):医療機器:M&Aディール及び事業提携情報
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. Its surgical instruments comprise forceps, scissors, needle …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆